limma powers differential expression analyses for RNA-sequencing and microarray studies
BPC-157 has exhibited some potential in scientific research studies to promote the transcription of the axin gene and thereby increase the expression of the protein
Weve seen what that looks like with compounded GLP-1s and the harm that has come with it the hospitalizations, contaminated products, and in some cases, death, PCAC cannot allow peptides to follow that same path. I don't understand how MAHA can scream about "gold standard" clinical trials for vaccines, but push for the approval of synthetic peptides without proper clinical trials
Comparison with Related Therapies Growth Factors and Regenerative Medicine Approaches BPC-157 and TB-500 can be compared to other growth factors and regenerative medicine approaches used in clinical practice
Notably, human clinical data are limited to a single pilot study of BPC 157 for one specific condition, and no human studies exist for TB500 peptide or the combined formulation